Trial NCT04354259
Publication Feld JJ, Lancet Respir Med, 2021
Primary outcome on the report: Proportion of individuals with a negative MT swab for SARS-CoV-2 at Day 7; Incidence of treatment-emergent severe adverse events (SAEs) by Day 14

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.